Answers are grounded in this paper and cite their sources.
Antimicrobial resistance (AMR) of microorganisms is one of the global challenges to public health. AMR already makes a significant contribution to morbidity and mortality worldwide today and may become one of the main causes of deaths in the near future. Despite the rapid spread of AMR, antibiotics remain the priority treatment for the most dangerous bacterial infectious diseases, and a search for new antibacterial agents remains a key area of antimicrobial therapy development. In recent years, targeted approaches to drug discovery have become increasingly important. The bacterial cell wall remains a primary target for antibacterial therapy, and its targeting holds great promise for the development of new drugs. To develop new approaches to overcoming the resistance of pathogenic microorganisms, it is necessary to analyze the existing data on the mechanisms of interaction between antibiotics and thier targets. The review examines known, relevant, and promising potential targets for the creation of new antibiotics that block the formation of bacterial cell walls. The materials discussed in the review expand our understanding of the molecular biology of antibiotics and their low-molecular-weight biologically active analogs.
No takes yet. Share an insight, caveat, or question.
Olsufyeva et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: